Skip to content
Screener

Reported August 11, 2026 · Before market open

EPS-$0.36Miss by $0.03
EPS estimate-$0.33

Next report

Nov 9, 2026 (in 2 months)
EPS estimate-$0.37

FAQ

When did Protara Therapeutics, Inc. report Q2 2026 earnings?
Protara Therapeutics, Inc. (TARA) reported Q2 2026 earnings on August 11, 2026 before market open.
What were Protara Therapeutics, Inc.'s Q2 2026 revenue and EPS?
Protara Therapeutics, Inc. reported eps of $-0.36 for Q2 2026.
Did Protara Therapeutics, Inc. beat estimates in Q2 2026?
EPS missed the consensus estimate of $-0.33 by $0.03.
How did Protara Therapeutics, Inc.'s Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 2.9% from $-0.35.
Where can I find Protara Therapeutics, Inc.'s Q2 2026 SEC filings?
You can read the 8-K earnings release (0001213900-26-087506) and the 10-Q periodic report (0001213900-26-087508) directly on SEC EDGAR. The filing index links above go to sec.gov.